Loading ...

Stock Quote srpt

srpt Stock Price Today

srpt Price History

srpt Stock Price History

srpt History

Last Price srpt

Close Price srpt

Day Change srpt

After Hours Quote srpt

Open Price srpt

Day Range srpt

Year Range srpt

Projected Yield srpt

Market Cap srpt

Stock Volume srpt

Average Volume srpt

Forward Price srpt

PE for srpt

PB for srpt

PS for srpt

PCF for srpt

price earnings ratio srpt

price to book ratio srpt

price to sales ratio srpt

price to cash flow ratio srpt

Stock Quote Sarepta Therapeutics Inc

Sarepta Therapeutics Inc Stock Price today

Sarepta Therapeutics Inc Price history

Sarepta Therapeutics Inc Stock Price history

Sarepta Therapeutics Inc history

Last Price Sarepta Therapeutics Inc

Close Price Sarepta Therapeutics Inc

Day Change Sarepta Therapeutics Inc

After Hours Quote for Sarepta Therapeutics Inc

Open Price Sarepta Therapeutics Inc

Day Range Sarepta Therapeutics Inc

Year Range Sarepta Therapeutics Inc

Projected Yield Sarepta Therapeutics Inc

Market Cap Sarepta Therapeutics Inc

Stock Volume Sarepta Therapeutics Inc

Average Volume Sarepta Therapeutics Inc

Forward Price Sarepta Therapeutics Inc

pe Sarepta Therapeutics Inc

pb Sarepta Therapeutics Inc

ps Sarepta Therapeutics Inc

pcf Sarepta Therapeutics Inc

price earnings ratio Sarepta Therapeutics Inc

price to book ratio Sarepta Therapeutics Inc

price to sales ratio Sarepta Therapeutics Inc

price to cash flow ratio Sarepta Therapeutics Inc

What Does This Company Do?
Sarepta Therapeutics Inc discovers and develops RNA-based therapeutics for the treatment of rare and infectious diseases. Its product candidates include eteplirsen, AVI-6002, AVI-6003, and AVI-7100.
Sector
Healthcare
Industry
Biotechnology
Stock Type
Distressed
Employees
146
Stock Style
Small Growth

Key Stats  SRPT More...

Key Stats SRPT

S&P 500 index data: S&P 500 Copyright ©

All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .

News  srpt - Sarepta Therapeutics Inc More...

Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days

Analysis  srpt - Sarepta Therapeutics Inc More...

Free Issue - Morningstar's Dividend Newsletter
More...

An investment is only as good as the cash it returns directly to your pockets. That's why Morningstar DividendInvestor's buy and sell recommendations are driven entirely by dividends. Our total-return strategy gives you carefully selected, picks that combine current income and income growth to generate large, reliable and growing cash returns. Click to try!

More reports srpt - Sarepta Therapeutics IncMore...

Click above to view more mutual fund data and stats for srpt - Sarepta Therapeutics Inc.

  • Performance
  • Asset Allocation
  • Dividend and Capital Gains Distribution
  • News, Alerts and Opinions
  • Video reports
  • Management
  • Filings

Ownership   SRPT More ...

Ownership SRPT

Columbia Acorn Z
Lord Abbett Fundamental Equity C
Fidelity® Select Biotechnology Portfolio
Lord Abbett Developing Growth A
Vanguard Small Cap Index
Stock Price Quote: srpt Sarepta Therapeutics Inc - XNAS - Morningstar
Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry

Previous: srpt - Sarepta Therapeutics Inc  |  Next: srsr - Sarissa Resources Inc